We examined whether the renin inhibitor, aliskiren, provides similar or greater protection than ACE inhibition from non-proliferative diabetic retinopathy and from the proliferative neoangiogenesis of oxygen-induced retinopathy.
Wilkinson-Berka, J., Tan, G., Binger, K., Sutton, L., McMaster, K., Deliyanti, D., Perera, G., Campbell, D., & Miller, A. (2011). Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat. Diabetologia, 54(10), 2724 - 2735. https://doi.org/10.1007/s00125-011-2239-9